Migraine in a specialist menopause clinic

Climacteric

Volumn 2, Issue 3, 1999, Pages 218-223

  MacGregor, E A ^a,b   Barnes, D ^a  

^a City of London Migraine Clinic   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Headache; Hormone replacement therapy; Menopause; Migraine

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; DISABILITY; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MENOPAUSE; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0032717907     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697139909038065     Document Type: Article

References (23)

1. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991;44: 1147-57
2. Stewart WF, Linet MS, Celentano DD, et al. Age-and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991; 34:1111-20
3. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993;43 (Suppl 3):6-10
4. MacGregor EA. 'Menstrual' migraine: towards a definition. Cephalalgia 1996;16:11-21
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 (Suppl 7):1-96
6. Hodson J, Al-Azzawi F. The frequency and pattern of headache in menopausal women. J Br Menopause Soc 1998;4:61-4
7. MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin 1997;15:125-41
8. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975;25: 239-50
9. Lichten E, Lichten J, Whitty A, et al. The confirmation of a biochemical marker for women's hormonal migraine: the depo-oestradiol challenge test. Headache 1996;36:367-71
10. Magos AL, Zilkha KJ, Studd JWW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiat 1983;46:1044-6
11. de Lignières B, Vincens M, Mauvais-Jarvis P, et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 1986;293:1540
12. Neri I, Granella F, Nappi R, et al. Characteristics of headache at menopause: a clinicepidemiological study. Maturitas 1993;17:31-7
13. Granella F, Sances G, Zanferrari C, et al. Migraine without aura and reproductive life events. Headache 1993;33:385-9
14. Kudrow L. The relationship of headache frequency to hormone use in migraine. Headache 1975;15:36-491
15. Dennerstein L, Laby B, Burrows GD, et al. Headache and sex hormone therapy. Headache 1978; 18:146-53
16. Evans MP, Fleming KC, Evans JM. Hormone replacement therapy: management of common problems. Mayo Clin Proc 1995;70:800-5
17. MacGregor EA. Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia 1999;19:124-5
18. Magos AL, Brewster E, Singh R, et al. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-6
19. Kaiser HJ, Meienberg O. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J Neurol 1993;240:195-7
20. MacGregor EA. Estrogen replacement and migraine aura. Headache 1999;in press
21. Wright GDS, Patel MK. Focal migraine and pregnancy. Br Med J 1986;293:1557-8
22. Hindfeld B, Nilsson O. Brain infarction in young adults. Acta Neurol Scand 1979;55:145-77
23. Hanington E, Jones RJ, Amess JAL. Platelet aggregation in response to 5HT in migraine patients taking oral contraceptives. Lancet 1982; 1:967-8